Coeptis Therapeutics

Dr. Colleen Delaney, Chief Development and Medical Officer

Oct. 11| 4:30pm | Rentschler ATMP Ballroom 

Wexford, PA


Coeptis Therapeutics (“Coeptis”) is a biopharmaceutical company developing innovative cell therapy platforms for patients with cancer. Coeptis was founded in 2017.

By using this website you agree to accept our Privacy Policy and Terms & Conditions